Advisor Group Holdings, Inc. Bio Xcel Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

$44.4 Billion
Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 14,875 shares of BTAI stock, worth $101,150. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,875

Holding current value

$101,150

% of portfolio

0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$1.18 - $2.05 $17,552 - $30,493	14,875 New	14,875 $26,000
Q4 2024 Jun 06, 2025	BUY	$0.32 - $0.73 $4,760 - $10,858	14,875 New	14,875 $5,000
Q3 2024 Nov 13, 2024	BUY	$0.53 - $1.34 $2,051 - $5,185	3,870 Added 83.59%	8,500 $5,000
Q2 2024 Aug 13, 2024	BUY	$1.14 - $2.97 $3,989 - $10,395	3,500 Added 309.73%	4,630 $5,000
Q1 2024 May 10, 2024	BUY	$1.95 - $4.04 $1,365 - $2,828	700 Added 162.79%	1,130 $3,000
Q4 2023 Feb 12, 2024	BUY	$2.32 - $5.51 $301 - $716	130 Added 43.33%	430 $1,000
Q3 2023 Nov 13, 2023	SELL	$2.49 - $11.85 $4,653 - $22,147	-1,869 Reduced 86.17%	300 $0
Q2 2023 Aug 10, 2023	BUY	$6.39 - $28.58 $2,517 - $11,260	394 Added 22.2%	2,169 $14,000
Q1 2023 May 12, 2023	SELL	$17.7 - $33.24 $14,797 - $27,788	-836 Reduced 32.02%	1,775 $33,000
Q4 2022 Feb 10, 2023	SELL	$10.25 - $22.43 $2,388 - $5,226	-233 Reduced 8.19%	2,611 $56,000
Q3 2022 Nov 14, 2022	SELL	$11.19 - $17.89 $7,363 - $11,771	-658 Reduced 18.79%	2,844 $34,000
Q2 2022 Aug 10, 2022	SELL	$9.03 - $21.55 $3,503 - $8,361	-388 Reduced 9.97%	3,502 $47,000
Q1 2022 May 04, 2022	SELL	$15.0 - $22.83 $171,480 - $260,992	-11,432 Reduced 74.61%	3,890 $94,000
Q3 2021 Nov 05, 2021	BUY	$23.84 - $32.03 $31,874 - $42,824	1,337 Added 9.56%	15,322 $465,000
Q2 2021 Aug 02, 2021	BUY	$29.06 - $38.83 $118,681 - $158,581	4,084 Added 41.25%	13,985 $406,000
Q1 2021 May 13, 2021	BUY	$39.04 - $64.6 $212,494 - $351,617	5,443 Added 122.1%	9,901 $428,000
Q4 2020 Feb 10, 2021	BUY	$42.46 - $56.58 $42,460 - $56,580	1,000 Added 28.92%	4,458 $206,000
Q3 2020 Nov 12, 2020	BUY	$37.44 - $64.63 $74,318 - $128,290	1,985 Added 134.76%	3,458 $152,000
Q2 2020 Aug 14, 2020	SELL	$17.62 - $58.71 $6,167 - $20,548	-350 Reduced 19.2%	1,473 $78,000
Q1 2020 May 18, 2020	BUY	$12.26 - $41.14 $22,349 - $74,998	1,823 New	1,823 $39,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

460K

Call Options Held

Put Options Held

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $191M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Bio Xcel Therapeutics, Inc. Transaction History